organophosphonates has been researched along with 24,25-dihydroxyvitamin d 3 in 1 studies
| Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (24,25-dihydroxyvitamin d 3) | Trials (24,25-dihydroxyvitamin d 3) | Recent Studies (post-2010) (24,25-dihydroxyvitamin d 3) |
|---|---|---|---|---|---|
| 9,968 | 880 | 3,596 | 816 | 33 | 82 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blackburn, J; Blom, A; Ishizawa, M; Lancaster, ST; Makishima, M; Mansell, JP | 1 |
1 other study(ies) available for organophosphonates and 24,25-dihydroxyvitamin d 3
| Article | Year |
|---|---|
24,25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation.
Topics: 24,25-Dihydroxyvitamin D 3; 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Calcitriol; Cell Differentiation; Fluorescent Dyes; Humans; Ketoconazole; Mitogens; Organophosphonates; Osteoblasts; Osteocalcin; Receptors, Calcitriol; Receptors, Lysophosphatidic Acid; Stereoisomerism; Transcription, Genetic; Tretinoin | 2014 |